PHATHOM PHARMACEUTICALS, INC. (PHAT)
Clinical trial NCT06851559 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-03-01 → 2027-01-01 3. primary completion date: 2026-12-01 → 2026-10-01 4. enrollment: 80 → 95 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical